does glp 1 increase risk of cancer Glucagon-like peptide-1 receptor agonists and gastrointestinal cancers: A systematic review and meta-analysis of randomized controlled trials GLP-1 receptor agonists in the

In a retrospective cohort study done by Garza et al

What This Means for Patients After several years of real-world use and growing scientific study, evidence suggests that GLP-1 medications may support mental health in addition to weight loss

The American journal of clinical nutrition , 92 (4), 810-817

This image was created by us with Canva

Updates include: GLP-1 receptor agonists preferred for patients with diabetes and MASH Clear referral to liver specialists when fibrosis risk is high Integration of fibrosis-4 (FIB-4) scoring into routine assessment Diabetes, liver disease, and obesity now sit within the same decision framework

For most people, a healthy calorie deficit is around 300500 calories per day